Form 10-K
Teva Pharmaceutical Industries Limited (TEVA) Company Profile & Overview - Stock Analysis
Teva lures Lundbeck chief Schultz with $52M package that makes him among pharma's top paid | Fierce Pharma
DEF 14A
After cost-cutting spree, Teva chief Schultz nabs big pay bump to nearly $16M | Fierce Pharma
Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with
DEF 14A
TEVA PHARMACEUTICAL INDUSTRIES LTD Form 10-Q Quarterly Report Filed 2022-05-03
Teva: New Generic Launches Will Benefit Earnings (NYSE:TEVA) | Seeking Alpha
DEF 14A
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
DEF 14A
DEF 14A
Teva Investor Relations on the App Store
TEVA - Short Interest - Teva Pharmaceutical Industries Ltd. (NYSE) Stock - Short Squeeze, Borrow Rates
TEVA Institutional Ownership and Shareholders - Teva Pharmaceutical Industries Ltd. (NYSE) Stock
TEVA Institutional Ownership and Shareholders - Teva Pharmaceutical Industries Ltd. (NYSE) Stock
Definitive Proxy Statement
US88167AAE10 Institutional Ownership and Shareholders - Teva Pharmaceutical Fin Neth 10/01/2026 3.150 Bond
DEF 14A
DEF 14A
Stock Forecast Based On a Predictive Algorithm | I Know First |Stock Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in Teva Stock
Teva confirms US FDA warning letter for Hangzhou, China API plant
As U.S. Domestic Issuer, Teva Reveals Top Stock Owners | Ctech
Bank of New York Mellon Corp Increases Investment in Teva Pharmaceutical Industries Despite Declining Revenue and FDA Warnings - Best Stocks
